Day CP.Non-alcoholic fatty liver disease:a massive problem[J].Clin Med,2011,11(2):176-178.
[2]
Dam-Larsen S,Franzmann M,Andersen IB,et al.Long term prognosis of fatty liver:risk of chronic liver disease and death[J].Gut,2004,53(5):750-755.
[3]
Zhang Y,Yang X,Shi H,et al.Effect ofα-linolenic acid on endoplasmic reticulum stress-mediated apoptosis of palmitic acid lipotoxicity in primary rat hepatocytes[J].Lipids Health Dis,2011,25(10):122.
[4]
Olszanecka-Glinianowicz M,Kuglin D,DbkowskaHuc'A,et al.Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome[J].Eur J Obstet Gynecol Reprod Biol,2011,154(1):51-56.
[5]
Polyzos SA,Kountouras J,Zavos C.Adiponectin in non-alcoholic fatty liver disease treatment:therapeutic perspectives and unresolved dilemmas[J].Int J Clin Pract,2011,65(3):373-374.
[6]
McDaniel JC,Ahijevych K,Belury M.Effect of n-3oral supplements on the n-6/n-3ratio in young adults[J].West J Nurs Res,2010,32(1):64-80.
[7]
Pascale A,Pais R,Ratziu V.An overview of nonalcoholic steatohepatitis:past,present and future directions[J].J Gastrointestin Liver Dis,2010,19(4):415-423.
